by Amy Cook | Jul 31, 2025 | Healthcare, News
Roosa joins the executive team to strengthen strategic initiatives surrounding laboratory licensing of the EPISEEK multicancer early detection tests and other laboratory products. Tucson, AZ — Precision Epigenomics is pleased to announce that Nannon Roosa will join...
by Amy Cook | Jul 1, 2025 | News
Watch the full episode on Youtube In the world of health and wellness, the phrase “early detection” is incredibly powerful, especially when it comes to cancer. We know that diagnosing cancer at an earlier stage generally leads to better outcomes. While...
by Amy Cook | Jul 1, 2025 | News
Watch the full episode on Youtube. Dr. Dan Rubin, host of Rubin on Point! hosted our very own Dr. Richard Bernert, COO of Precision Epigenomics! With a background as a pathologist – essentially the expert who helps clinicians understand disease at the cellular level –...
by pesbm | Jun 24, 2025 | News
The data support the EPISEEK™ test’s potential as an accurate and cost-effective solution for multi-cancer early detection through a simple blood draw. PHOENIX, AZ, UNITED STATES – June 2, 2025 /EINPresswire.com/ — Precision Epigenomics, a biotechnology...
by pesbm | Feb 21, 2025 | News
Tucson’s News 13 recently highlighted Precision Epigenomic’s groundbreaking work developing EPISEEK™, a multi-cancer early detection blood test. The segment focused on EPISEEK that looks for signals shared by more than 50 types of cancer through a simple blood draw,...
by pesbm | Jan 13, 2025 | News
Precision Epigenomics announced that the company presented data supporting the critical role of its melanoma classifier. TUCSON, Az. - Nov. 21, 2024 - /EINPresswire.com/ — Precision Epigenomics, the developer of the EPISEEK™ multi-cancer detection (MCD) test,...
